Item 2. Unregistered Sales of Equity Securities
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer purchases of equity securities for the three months ended September 30, 2024 were as follows:
ISSUER PURCHASES OF EQUITY SECURITIES
($ in millions)
Period Total Number
of Shares
Purchased (1)
Average Price
Paid Per
Share Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Approximate Dollar Value of Shares
That May Yet Be Purchased
Under the Plans or Programs (1)
July 1 - July 31
880,451 $126.08 880,451 $3,217
August 1 - August 31
1,391,425 $114.53 1,391,425 $3,058
September 1 - September 30
1,496,936 $116.19 1,496,936 $2,884
Total 3,768,812 $117.89 3,768,812
(1) Shares purchased during the period were made as part of a plan approved by the Board of Directors in October 2018 to purchase up to $10 billion of Merck’s common stock for its treasury.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.